Stay updated on Efficacy & Safety of M2951 in Relapsing MS Clinical Trial

Sign up to get notified when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 error page, with its footer revision changing from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T11:22:43.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, indicating access is blocked; the new markup reflects an error state rather than the typical study information on the page.
    Difference
    20%
    Check dated 2026-09-20T03:55:35.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now includes an explicit note of the 2016 U.S. NIH Grant/Contract funding, and the revision tag has been updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T23:39:10.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page shows a new revision label (v3.6.5) replacing the previous v3.6.4, indicating an update to the site’s revision history rather than changes to trial content.
    Difference
    0.0%
    Check dated 2026-08-08T20:50:19.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The location entries for Zaporizhzhia in Ukraine have been updated to Zaporizhzhya with postal codes 69035 and 69600, adding two entries and removing the previous Zaporizhzhia spellings for those codes to reflect a standardized city name.
    Difference
    0.1%
    Check dated 2026-08-01T18:39:07.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page shows a revision tag update from v3.6.3 to v3.6.4, indicating a small software update to the site hosting the page.
    Difference
    0.0%
    Check dated 2026-07-25T13:17:12.000Z thumbnail image

Stay in the know with updates to Efficacy & Safety of M2951 in Relapsing MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.